By utilizing DNA as a functional organic material, we are developing a “DNA linker technology” that enables precise conjugation of antibodies with drugs and functional molecules, alongside related applications such as cell adhesion and enzyme-free nucleic acid detection. Our unique molecular design enhances the performance and multifunctionality of diverse materials, establishing foundational technologies for ADC drug development, 3D cell models, and diagnostic platforms. Furthermore, we expand these technologies into research support and collaborative R&D to accelerate industrial application and societal implementation.
Development of cancer treatment equipment using optical electromagnetic waves
A startup developing medical devices that diagnose and treat sleep-disordered breathing using non-contact sensing and digital signal processing technology. We provide a new sleep monitoring solution that requires no wearable devices, minimizes burden, and respects privacy.
A startup developing kidney disease treatments and cell therapies using iPS cell technology, expanding its achievements in the kidney disease field while advancing applications to the liver and pancreas.
BEL, Inc. is a deep-tech company specializing in materials science and surface engineering, focusing on the development and social implementation of advanced functional surfaces with antibacterial, antiviral, and anti-biofilm properties. The company integrates polymer science, additive manufacturing (3D printing), and surface microstructure control to create next-generation functional coatings for applications in medical devices, infrastructure, environmental systems, and marine environments. BEL actively promotes international collaboration with universities, research institutes, and industrial partners, aiming to advance materials innovation by integrating materials science with digital technologies such as data science and digital twin methodologies.